Fig. 2From: Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter studyA Cumulative of overall survival over 28Â days between severe patients with corticosteroid therapy and non-corticosteroid before IPTW analysis on admission. B Cumulative of overall survival over 28Â days between severe patients with corticosteroid therapy and non-corticosteroid after IPTW analysis on admissionBack to article page